Compliance

State Drug Price Transparency

Reporting obligations follow a product through its entire lifecycle

Each state has imposed its own independent reporting requirements on manufacturers

States have developed State Drug Price Transparency (DPT) legislation in response to the increasing pressure for greater price transparency within the US. Navigating this highly dynamic and evolving regulatory landscape of DPT requires a dedicated effort due to its ever-changing nature.

  • An increasing number of states have enacted laws requiring manufacturers to report pricing and other information.
  • More than 20 additional states are expected to enact similar laws in the next two years.
  • More than 100 bills are currently pending at the state and federal level.

State Drug Price Transparency includes requirements prior to FDA approval and launch. Not only is receiving a PDUFA date from the FDA an essential step in launching your product, but the clock on reporting also begins the day your PDUFA date is received. All drug manufacturers have some sort of price reporting obligation, even if no pricing action is taken on the products.

High-Level Overview of
our DPT Service

At Two Labs, we oversee hundreds of state submissions for 40+ clients every year, maintaining their DPT compliance by assisting with quarterly and annual standard reporting, and providing ongoing support. 

Dedicated Account Manager

You will have the support of a dedicated account manager on your account with support from Subject Matter Experts.

In-House Regulatory Analysts

Our in-house regulatory analysts will proactively monitor the ever-changing regulatory landscape and legislation for you.

Access to Cloud-Based Content Repository

You will have access to our cloud-based content repository for all key documents, including SOP, reports submitted to the state, and evidence of state receipt of submission.

Ongoing Reporting and Monitoring

You will have assistance with ongoing reporting triggered by requirements, and we monitor upcoming reporting deadlines, assist with submissions, confirmations, and much more.

We handle the entire process for our clients, including filling out and submitting reports and changes to the states to meet reporting requirements, saving them time and money. Two Labs serves as your long-term strategic partner to maintain DPT compliance and avoid fines through any report triggering events, including price increases, new product launches, new drug applications, and fixed ongoing dates.

Let’s Get Started.

State Drug Price Transparency

Reporting obligations follow a product through its entire lifecycle

About

State Drug Price Transparency

Each state has imposed its own independent reporting requirements on manufacturers

States have developed State Drug Price Transparency (DPT) legislation in response to the increasing pressure for greater price transparency within the US. Navigating this highly dynamic and evolving regulatory landscape of DPT requires a dedicated effort due to its ever-changing nature.

  • An increasing number of states have enacted laws requiring manufacturers to report pricing and other information.
  • More than 20 additional states are expected to enact similar laws in the next two years.
  • More than 100 bills are currently pending at the state and federal level.

State Drug Price Transparency includes requirements prior to FDA approval and launch. Not only is receiving a PDUFA date from the FDA an essential step in launching your product, but the clock on reporting also begins the day your PDUFA date is received. All drug manufacturers have some sort of price reporting obligation, even if no pricing action is taken on the products.

High-Level Overview of Our DPT Service

At Two Labs, we oversee hundreds of state submissions for 40+ clients every year, maintaining their DPT compliance by assisting with quarterly and annual standard reporting, and providing ongoing support.

Dedicated Account Manager

You will have the support of a dedicated account manager on your account with support from Subject Matter Experts.

In-House Regulatory Analysts

Our in-house regulatory analysts will proactively monitor the ever-changing regulatory landscape and legislation for you.

Access to Cloud-Based Content Repository

You will have access to our cloud-based content repository for all key documents, including SOP, reports submitted to the state, and evidence of state receipt of submission.

Ongoing Reporting and Monitoring

You will have assistance with ongoing reporting triggered by requirements, and we monitor upcoming reporting deadlines, assist with submissions, confirmations, and much more.

We handle the entire process for our clients, including filling out and submitting reports and changes to the states to meet reporting requirements, saving them time and money. Two Labs serves as your long-term strategic partner to maintain DPT compliance and avoid fines through any report triggering events, including price increases, new product launches, new drug applications, and fixed ongoing dates.

What can we help you with today?

No matter where you are in the process, we’re here to support, advise, and implement key strategies to ensure the success of your product.